LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
SON
Sonoco Products Company
SON lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SON Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
SON's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SON PE Valuation
SON has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SON Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect SON's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.61 | — |
| Q3 2026 | -$2.30 | -137% |
| Q2 2026 | $6.29 | +13% |
| Q1 2026 | $10.20 | +562% |
| Q4 2025 | $10.07 | +510% |
| Q3 2025 | $6.30 | +116% |
| Q2 2025 | $5.58 | +50% |
| Q1 2025 | $1.54 | -61% |
| Q4 2024 | $1.65 | -66% |
SON has swung to a loss: it lost $2.30 per share over the past year, after a profit the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SON on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | -4.2% |
| Q2 2026 | $1.9B | -1.3% |
| Q1 2026 | $1.7B | -1.9% |
| Q4 2025 | $1.8B | +30% |
| Q3 2025 | $2.1B | +27% |
| Q2 2025 | $1.9B | +18% |
| Q1 2025 | $1.7B | +4.4% |
| Q4 2024 | $1.4B | -17% |
SON's revenue has held roughly level: $2B last quarter, down 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -31% | -40 points |
| Q2 2026 | 10% | +1 points |
| Q1 2026 | 7.6% | +0.2 points |
| Q4 2025 | 29% | +33 points |
| Q3 2025 | 9.2% | +1.5 points |
| Q2 2025 | 9.2% | +0.5 points |
| Q1 2025 | 7.4% | +0.5 points |
| Q4 2024 | -4% | -12 points |
SON has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $221.9M | -1.6% |
| Q2 2026 | $236.9M | +140% |
| Q1 2026 | -$430M | -$129.3M |
| Q4 2025 | $322.3M | +17% |
| Q3 2025 | $225.6M | +220% |
| Q2 2025 | $98.6M | +516% |
| Q1 2025 | -$300.8M | -477% |
| Q4 2024 | $274.3M | +74% |
SON has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 5.3x | High |
| Q2 2025 | 6.2x | High |
| Q1 2025 | 9.3x | High |
| Q4 2024 | 9.4x | High |
SON's net debt is about 5.6 years of its operating earnings (EBITDA), up from 5.3 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 22.6 | Neutral |
SON's weekly RSI is 44 (neutral) and its Stochastic is 23 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SON PE vs Consumer Cyclical Sector
| Metric | SON | Sector median | Relative |
|---|---|---|---|
| PE | 7.9x | 18x | 56% below |
| PE % | 15 | 47 | 32 pts below |
SON has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $49.5 | 1.6% below |
| 20 week MA | $53.1 | 8.2% below |
| 50 week MA | $51.3 | 5% below |
| 100 week MA | $48.3 | 0.9% above |
| 200 week MA | $52.3 | 6.8% below |
SON has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.3 | $59.4 | -3.1% |
| 2021 | $59.4 | $55.5 | -6.6% |
| 2022 | $55.5 | $60.4 | +8.9% |
| 2023 | $60.4 | $55.9 | -7.5% |
| 2024 | $55.9 | $48.9 | -12% |
| 2025 | $48.9 | $43.5 | -11% |
| 2026 YTD | $43.5 | $48.7 | +12% |
SON has the edge over LCID on returns for 2026, with the stronger performance.